| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 280.62M | 270.04M | 202.53M | 182.71M | 137.76M | 143.31M |
| Gross Profit | 79.19M | 90.42M | 76.27M | 64.86M | 56.60M | 53.36M |
| EBITDA | 34.40M | 35.57M | 29.25M | 23.07M | 21.79M | 21.36M |
| Net Income | 18.26M | 19.25M | 15.32M | 11.36M | 9.20M | 5.46M |
Balance Sheet | ||||||
| Total Assets | 413.94M | 396.58M | 252.50M | 210.69M | 203.17M | 190.88M |
| Cash, Cash Equivalents and Short-Term Investments | 53.16M | 74.65M | 55.16M | 41.45M | 40.37M | 32.29M |
| Total Debt | 95.13M | 78.88M | 40.51M | 34.98M | 39.52M | 37.38M |
| Total Liabilities | 247.03M | 236.49M | 142.66M | 110.91M | 113.98M | 105.83M |
| Stockholders Equity | 165.48M | 158.61M | 108.67M | 97.02M | 83.97M | 79.31M |
Cash Flow | ||||||
| Free Cash Flow | -27.65M | 38.00M | 16.36M | 11.29M | 17.52M | 14.97M |
| Operating Cash Flow | -10.79M | 51.18M | 23.02M | 16.52M | 19.52M | 16.22M |
| Investing Cash Flow | -89.57M | -93.65M | -6.16M | -6.11M | -2.37M | -2.54M |
| Financing Cash Flow | 69.18M | 46.18M | -16.92M | -10.57M | -8.70M | -1.55M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.75B | 58.24 | 5.21% | 1.27% | 0.84% | -62.73% | |
69 Neutral | £434.02M | 23.19 | 13.24% | 1.58% | 23.91% | -14.66% | |
67 Neutral | £6.71B | 23.63 | 46.10% | 0.56% | 7.36% | 48.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.33B | 27.67 | 14.44% | 1.64% | -2.53% | 22.25% | |
61 Neutral | £54.02B | 28.13 | 17.59% | 1.99% | 11.60% | 8.03% | |
58 Neutral | £2.41B | -12.58 | ― | 2.00% | -4.59% | -256.51% |
Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will deliver a live investor presentation via Equity Development on 14 January 2026, where they will discuss the company’s recent half-year results and outline its corporate strategy. The webinar, which is free and open to both existing and potential shareholders, will include a Q&A session and be recorded for later viewing, underscoring Cohort’s efforts to enhance transparency and engage more directly with investors as it continues to develop its position in the international defence technology market.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has confirmed that as at 31 December 2025 its issued share capital comprised 46,950,593 ordinary shares of 10 pence each, with each share carrying one voting right and no shares held in treasury. This updated total voting rights figure provides the basis for shareholders and investors to calculate whether they are required to disclose holdings or changes in their interests under UK market transparency rules, reinforcing regulatory clarity around the company’s capital structure.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will host a live investor presentation on the Engage Investor platform on 12 January at 2:30pm GMT. During the session, they will discuss the group’s recent half-year results and outline its corporate strategy, with current shareholders and prospective investors invited to attend, follow the company via a personalised investor hub and submit questions before or during the event, underscoring Cohort’s efforts to enhance transparency and engagement with the investment community.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that its Chief Executive, Andrew Thomis, transferred 80,000 ordinary shares to his spouse without any change in his beneficial interest, which remains at 186,600 shares, representing 0.40% of the company’s total issued share capital. This transaction, conducted on the London Stock Exchange AIM, is part of regulatory compliance and does not impact the company’s operations or market positioning.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that Simon Walther, the Finance Director, transferred 75,000 ordinary shares to his spouse without any financial consideration, maintaining his beneficial interest in the company at 0.32% of the total issued share capital. This transaction, conducted outside of a Main Market, is in compliance with the EU Market Abuse Regulation, and does not alter the overall shareholding structure, reflecting a neutral impact on the company’s operations and market positioning.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc reported a 9% increase in revenue to £128.8 million for the first half of 2025, driven by contributions from EM Solutions and other group businesses, except MCL. Despite a slight decrease in adjusted operating profit to £9.7 million, the company maintained a strong order book of £604.5 million and increased its interim dividend by 10%, reflecting confidence in future growth. The Communications and Intelligence division saw a significant profit increase, while the Sensors and Effectors division experienced lower margins due to specific project contributions. The company expects improved performance in the second half of the year, supported by a robust order book and positive outlook for organic growth in core defence markets.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc, an AIM-listed independent technology group, announced its total voting rights as of November 30, 2025, with an issued share capital of 46,930,296 ordinary shares, each carrying one vote. This update allows shareholders to calculate their interest in the company’s shares under the FCA’s Disclosure Guidance and Transparency Rules, impacting stakeholders’ understanding of their shareholding and potential voting power.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1179.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that it will release its half-year results for the six months ending October 31, 2025, on December 10, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1179.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc, an independent technology group listed on AIM, announced that its issued share capital as of October 31, 2025, consists of 46,915,549 ordinary shares, each carrying one vote. This figure is significant for shareholders as it serves as the denominator for calculating their interests under the FCA’s Disclosure Guidance and Transparency Rules. The announcement underscores Cohort’s commitment to transparency and regulatory compliance, which is crucial for maintaining investor confidence and market integrity.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1467.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that Simon Walther, the Finance Director, exercised options over 1,015 ordinary shares at a price of 532 pence per share under the Cohort plc Savings Related Share Option Scheme. This transaction increases Mr. Walther’s beneficial interest to 150,818 shares, representing 0.32% of the company’s total issued share capital. This move reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially impacting stakeholder confidence and market perception.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1467.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, have purchased shares under the company’s Share Incentive Plan. This transaction reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially strengthening stakeholder confidence in Cohort’s leadership and strategic direction.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1469.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.